203 related articles for article (PubMed ID: 36929458)
1. The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism.
Düğer H; Bostan H; Gül Ü; Uçan B; Hepşen S; Sakız D; Akhanlı P; Çakal E; Kızılgül M
J Endocrinol Invest; 2023 Sep; 46(9):1935-1940. PubMed ID: 36929458
[TBL] [Abstract][Full Text] [Related]
2. Reliability of calcium-phosphorus (Ca/P) ratio as a new, accurate and inexpensive tool in the diagnosis of some Ca-P disorders.
Madeo B; De Vincentis S; Kara E; Vescini F; Trenti T; Guaraldi G; Rochira V
J Endocrinol Invest; 2019 Sep; 42(9):1041-1049. PubMed ID: 30796757
[TBL] [Abstract][Full Text] [Related]
3. Serum Phosphate: A Neglected Test in the Clinical Management of Primary Hyperparathyroidism.
Castellano E; Attanasio R; Boriano A; Pellegrino M; Borretta G
J Clin Endocrinol Metab; 2022 Jan; 107(2):e612-e618. PubMed ID: 34519347
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Moderate Hypophosphatemia on the Clinical Management of Primary Hyperparathyroidism.
Güneş E; Güneş M
Cureus; 2023 Aug; 15(8):e44115. PubMed ID: 37638278
[TBL] [Abstract][Full Text] [Related]
5. Hypomagnesemia may be associated with symptomatic disease in patients with primary hyperparathyroidism.
Düğer H; Uçan B; Çalışkan M; Bostan H; Demirci T; Gül Ü; Çakal E; Kızılgül M
Endocrine; 2024 Feb; 83(2):466-472. PubMed ID: 37922091
[TBL] [Abstract][Full Text] [Related]
6. Sporadic primary hyperparathyroidism and stone disease: a comprehensive metabolic evaluation before and after parathyroidectomy.
Marchini GS; Faria KVM; Torricelli FCM; Monga M; Srougi M; Nahas WC; Mazzucchi E
BJU Int; 2018 Feb; 121(2):281-288. PubMed ID: 29124877
[TBL] [Abstract][Full Text] [Related]
7. Does renal function improve after parathyroidectomy in primary hyperparathyroidism?
García-Martín F; Guadalix S; García-Boyano F; Melón Peña N; Martínez Pueyo JI; Callejas Martínez R; Praga Terente M
Nefrologia (Engl Ed); 2019; 39(2):160-167. PubMed ID: 30459009
[TBL] [Abstract][Full Text] [Related]
8. The impact of obesity on the presentation of primary hyperparathyroidism.
Tran H; Grange JS; Adams-Huet B; Nwariaku FE; Rabaglia JL; Woodruff SL; Holt SA; Maalouf NM
J Clin Endocrinol Metab; 2014 Jul; 99(7):2359-64. PubMed ID: 24684459
[TBL] [Abstract][Full Text] [Related]
9. Primary hyperparathyroidism: findings from the retrospective evaluation of cases over a 6-year period from a regional UK centre.
Pappachan JM; Elnaggar MN; Sodi R; Jbeili K; Smith PR; Lahart IM
Endocrine; 2018 Oct; 62(1):174-181. PubMed ID: 30019307
[TBL] [Abstract][Full Text] [Related]
10. Phosphate: An underrated component of primary hyperparathyroidism.
Bhadada SK; Ghosh J; Pal R; Mukherjee S
Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101837. PubMed ID: 37926613
[TBL] [Abstract][Full Text] [Related]
11. [Normocalcemic with elevated post-operative parathormone in primary hyperpara-thyroidism: 9 case reports and literature review].
Xie LD; Wang N; Zhang JP; Wang X; Chen XP; Zhang B; Bu S
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):573-579. PubMed ID: 34145863
[TBL] [Abstract][Full Text] [Related]
12. [Asymptomatic primary hyperparathyroidism : Operation or observation?].
Gollisch K; Siggelkow H
Internist (Berl); 2021 May; 62(5):496-504. PubMed ID: 33710361
[TBL] [Abstract][Full Text] [Related]
13. Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.
Govind K; Paruk IM; Motala AA
BMC Endocr Disord; 2024 Apr; 24(1):53. PubMed ID: 38664758
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of patients with mildly elevated parathormone and calcium levels.
Parikh PP; Allan BJ; Lew JI
World J Surg; 2014 Jun; 38(6):1289-95. PubMed ID: 24615605
[TBL] [Abstract][Full Text] [Related]
15. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
Lim V; Clarke BL
J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
[TBL] [Abstract][Full Text] [Related]
16. Screening for asymptomatic nephrolithiasis in primary hyperparathyroidism patients is warranted.
Zabolotniuk T; Guo M; Kwon M; Watanabe A; Teichman JMH; Wiseman SM
Am J Surg; 2024 May; 231():91-95. PubMed ID: 38480062
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in the presentation, course and outcomes of primary hyperparathyroidism.
Dadon T; Tsvetov G; Levi S; Gorshtein A; Slutzky-Shraga I; Hirsch D
Maturitas; 2021 Mar; 145():12-17. PubMed ID: 33541557
[TBL] [Abstract][Full Text] [Related]
18. What Predicts Recurrent Kidney Stone after Parathyroidectomy in Patients with Primary Hyperparathyroidism?
Islam AK; Holt S; Reisch J; Nwariaku F; Antonelli J; Maalouf NM
J Am Coll Surg; 2020 Jul; 231(1):74-82. PubMed ID: 32330575
[TBL] [Abstract][Full Text] [Related]
19. Renal Dysfunction in Primary Hyperparathyroidism is associated with nephrolithiasis, elevated serum calcium-phosphate product and parathormone levels.
Banerjee M; Kar A; Ahamed J; Bhattacharjee R; Maitra D; Maisnam I; Das TC; Sahana PK; Chowdhury S; Mukhopadhyay S
Endocrine; 2024 Mar; 83(3):757-762. PubMed ID: 38091198
[TBL] [Abstract][Full Text] [Related]
20. Hypomagnesuria is Associated With Nephrolithiasis in Patients With Asymptomatic Primary Hyperparathyroidism.
Saponaro F; Marcocci C; Apicella M; Mazoni L; Borsari S; Pardi E; Di Giulio M; Carlucci F; Scalese M; Bilezikian JP; Cetani F
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32369583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
